Home » Topics » BioWorld Science

BioWorld Science
RSS

Novel compound targets multiple immune checkpoint elements

April 19, 2018

Pear Therapeutics and Sandoz sign agreement for prescription digital therapeutics

April 19, 2018

Institut Pasteur Korea divulges new compounds for influenza

April 19, 2018

FDA grants priority review to sBLA for Opdivo in previously treated SCLC

April 19, 2018

Procter & Gamble to acquire Merck KGaA's consumer health business

April 19, 2018

Cellipse identifies LIMK-1 and/or LIMK-2 inhibitors

April 19, 2018

Cancer Research Technology patents new CDC7 inhibitors

April 19, 2018

Mercaptor develops new class of drugs called captons

April 19, 2018

Opiant Pharmaceuticals receives grant to develop intranasal nalmefene

April 19, 2018

Taiho presents highly selective RET inhibitor TAS-0286

April 19, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...